Erratum to: 'Oral rivaroxaban for Japanese patients with symptomatic venous thromboembolism - the J-EINSTEIN DVT and PE program'

Affiliations

¹ Department of Cardiology and Nephrology, Mie University Graduate School of Medicine, Mie, Japan.
² Division of Cardiology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan.
³ Division of Cardiovascular, Respiratory and general surgery, Nihon University School of Medicine, Tokyo, Japan.
⁴ Department of Cardiology, National Hospital Organization, Kanazawa Medical Center, Kanazawa, Japan.
⁵ Department of Cardiovascular Surgery, Kanazawa Medical University, Ishikawa, Japan.
⁶ Maastricht University Medical Center, Maastricht, The Netherlands.
⁷ Bayer HealthCare Pharmaceuticals, Wuppertal, Germany.
⁸ Bayer Yakuhin Ltd, Osaka, Japan.

Published Erratum

Norikazu Yamada et al. Thromb J. 2016.

. 2016 May 23:14:11.

doi: 10.1186/s12959-016-0085-1. eCollection 2016.

¹ Department of Cardiology and Nephrology, Mie University Graduate School of Medicine, Mie, Japan.
² Division of Cardiology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan.
³ Division of Cardiovascular, Respiratory and general surgery, Nihon University School of Medicine, Tokyo, Japan.
⁴ Department of Cardiology, National Hospital Organization, Kanazawa Medical Center, Kanazawa, Japan.
⁵ Department of Cardiovascular Surgery, Kanazawa Medical University, Ishikawa, Japan.
⁶ Maastricht University Medical Center, Maastricht, The Netherlands.
⁷ Bayer HealthCare Pharmaceuticals, Wuppertal, Germany.
⁸ Bayer Yakuhin Ltd, Osaka, Japan.

Abstract

[This corrects the article DOI: 10.1186/s12959-015-0035-3.].

Oral rivaroxaban for Japanese patients with symptomatic venous thromboembolism - the J-EINSTEIN DVT and PE program.
Yamada N, Hirayama A, Maeda H, Sakagami S, Shikata H, Prins MH, Lensing AW, Kato M, Onuma J, Miyamoto Y, Iekushi K, Kajikawa M. Yamada N, et al. Thromb J. 2015 Jan 17;13:2. doi: 10.1186/s12959-015-0035-3. eCollection 2015. Thromb J. 2015. PMID: 25717286 Free PMC article.

1. Yamada N, Hirayama A, Maeda H, Sakagami S, Shikata H, Prins MH, Lensing AWA, Kato M, Onuma J, Miyamoto Y, Iekushi K, Kajikawa M. Oral rivaroxaban for Japanese patients with symptomatic venous thromboembolism – the J-EINSTEIN DVT and PE program. Thromb J. 2015;13:2. doi: 10.1186/s12959-015-0035-3. - DOI - PMC - PubMed